Pharma-Bio Serv (PBSV) Asset Utilization Ratio (2011 - 2026)

Pharma-Bio Serv has reported Asset Utilization Ratio for 14 years, with the latest figure at 0.65 in Q1 2026.

• For the quarter ending Q1 2026, Asset Utilization Ratio rose 9.38% year-over-year to 0.65; the trailing twelve-month figure through Jan 2026 stood at 0.65 (up 9.38% YoY), and the FY2025 full-year result was 0.6, up 14.41% from the prior year.
• Asset Utilization Ratio for Q1 2026 stood at 0.65, down from 0.66 in the prior quarter.
• The five-year high for Asset Utilization Ratio was 1.01 in Q3 2022, with the low at 0.58 in Q4 2024.
• Historically, Asset Utilization Ratio has averaged 0.78 across 5 years, with a median of 0.77 in 2024.
• Annual changes were most pronounced in 2022 — Asset Utilization Ratio soared 45.34% — and 2024, when it sank 30.95%.
• Pharma-Bio Serv's Asset Utilization Ratio stood at 0.95 in 2022, then fell by 10.78% to 0.84 in 2023, then slumped by 30.95% to 0.58 in 2024, then gained by 13.32% to 0.66 in 2025, then declined by 1.83% to 0.65 in 2026.
• The last three Asset Utilization Ratio figures came in at 0.65 (Q1 2026), 0.66 (Q4 2025), and 0.67 (Q3 2025), per Business Quant data.